Scarica l'app Stockscreener
79.80
1.47%
1.155
Dopo l'orario di chiusura:
79.70
-0.095
-0.12%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché TMDX Giù?
Forum
Previsione
Precedente Chiudi:
$78.64
Aprire:
$79.81
Volume 24 ore:
1.22M
Relative Volume:
1.49
Capitalizzazione di mercato:
$2.77B
Reddito:
$635.89M
Utile/perdita netta:
$171.92M
Rapporto P/E:
18.31
EPS:
4.357
Flusso di cassa netto:
$151.36M
1 W Prestazione:
-6.44%
1M Prestazione:
-5.33%
6M Prestazione:
-20.76%
1 anno Prestazione:
-31.25%
Intervallo 1D:
$77.14
$80.85
Intervallo di 1 settimana:
$77.14
$86.38
Portata 52W:
$60.10
$156.00
Transmedics Group Inc Stock (TMDX) Company Profile
Nome
Transmedics Group Inc
Settore
Industria
Telefono
(978) 552-0900
Indirizzo
200 MINUTEMAN ROAD, ANDOVER, MA
Compare TMDX vs ABT, MDT, SYK, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TMDX
Transmedics Group Inc
|
79.80 | 2.96B | 635.89M | 171.92M | 151.36M | 4.357 |
ABT
Abbott Laboratories
|
97.50 | 175.27B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
86.38 | 113.38B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
275.43 | 104.47B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
42.60 | 63.65B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
85.15 | 49.74B | 6.30B | 1.07B | 1.09B | 1.8406 |
Transmedics Group Inc Stock (TMDX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-23 | Aggiornamento | Needham | Hold → Buy |
| 2025-10-13 | Iniziato | Jefferies | Buy |
| 2025-09-16 | Iniziato | Evercore ISI | Outperform |
| 2025-09-04 | Iniziato | Stifel | Hold |
| 2024-12-17 | Downgrade | JP Morgan | Overweight → Neutral |
| 2024-11-22 | Downgrade | Needham | Buy → Hold |
| 2024-10-29 | Reiterato | Needham | Buy |
| 2024-10-29 | Reiterato | Oppenheimer | Outperform |
| 2024-09-24 | Iniziato | Robert W. Baird | Outperform |
| 2024-08-21 | Iniziato | Needham | Buy |
| 2024-06-06 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-06-04 | Iniziato | Stephens | Overweight |
| 2024-03-28 | Iniziato | Piper Sandler | Overweight |
| 2023-07-19 | Iniziato | Robert W. Baird | Outperform |
| 2022-08-02 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2020-10-08 | Downgrade | JP Morgan | Overweight → Neutral |
| 2020-04-07 | Iniziato | Oppenheimer | Outperform |
| 2019-05-28 | Iniziato | Canaccord Genuity | Buy |
| 2019-05-28 | Iniziato | Cowen | Outperform |
| 2019-05-28 | Iniziato | JP Morgan | Overweight |
| 2019-05-28 | Iniziato | Morgan Stanley | Equal-Weight |
Mostra tutto
Transmedics Group Inc Borsa (TMDX) Ultime notizie
TransMedics Group, Inc. (TMDX) Stock Forecasts - Yahoo Finance
TransMedics Group (TMDX), Why Is It Back In The Spotlight? - Simply Wall Street
Is TransMedics Group (NASDAQ:TMDX) Facing a Real Market Test? - Kalkine Media
TMDX5812024 Bond Profile: Coupon and Redemption - TradingView
TransMedics Group, Inc. (TMDX) Stock Price, News, Quote & History - Yahoo! Finance Canada
TransMedics CFO Fernando N. Araujo Files Initial SEC Ownership Disclosure Reporting No Shares - Kalkine Media
[Form 3] TransMedics Group, Inc. Initial Statement of Beneficial Ownership - Stock Titan
Net margin % of TransMedics Group, Inc. – HAN:8T8 - TradingView
TransMedics Director David Weill Purchases $109,000 of Stock -- Should Investors Buy Too? - Yahoo Finance
ETFs Investing in TransMedics Group, Inc. Stocks - TradingView
8T8 Forecast — Price Target — Prediction for 2027 - TradingView
A Look at TransMedics Group Inc (TMDX) After 3.0% Decline -- GF Value $159.18 vs Price $82.73 - GuruFocus
TransMedics offers a unique organ transplant te... - Pluang
TransMedics Offers Attractive Entry Point, With Upside Potential Outweighing Risks (TMDX) - Seeking Alpha
Investors urged to act on possible TransMedics leadership breaches and seek legal relief. - Pluang
Did TransMedics Group, Inc. Insiders Breach their Fiduciary Duties to Shareholders? - The Conway Daily Sun
Investors Purchase Large Volume of TransMedics Group Put Options (NASDAQ:TMDX) - MarketBeat
A Look at TransMedics Group Inc (TMDX) After 3.6% Decline -- GF Value $158.92 vs Price $83.90 - GuruFocus
(TMDX) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Analysts Offer Insights on Healthcare Companies: DBV Technologies SA – American (DBVT) and TransMedics Group (TMDX) - The Globe and Mail
Donald TrumpTRANSMEDICS GROUP INC Trump Trade on Jul. 08, 2026 - Quiver Quantitative
TransMedics Group, Inc. (TMDX) Stock Analysis: A 12.59% Potential Upside in the Revolutionary Organ Transplant Space - DirectorsTalk Interviews
TMDX Q2 2026 Earnings: EPS Misses Estimate as Shares Edge LowerDiluted EPS Report - careplusvn.com
An Organ Transplant Company With Its Own Fleet Of Aircraft – Insider Weekends (NASDAQ:TMDX) - Seeking Alpha
TransMedics Group stock holds near model value as analysts stay positive - AD HOC NEWS
TransMedics Group, Inc.Common Stock (NQ: TMDX - The Chronicle-Journal
TransMedics Stock: Waiting On 2027 Catalysts (NASDAQ:TMDX) - Seeking Alpha
2 Stocks Down 28% and 34% to Buy and Hold - The Motley Fool
TransMedics Group, Inc. (TMDX) Presents at 2026 Global Healthcare ConferenceSlideshow - Seeking Alpha
TransMedics Group Jumps 6.5% Amid Sector-Wide Rally - AlphaStreet
Insider Buying: TransMedics Group (NASDAQ:TMDX) Director Buys 1,336 Shares of Stock - MarketBeat
Director buys TransMedics (TMDX) stock at $81.63 a share - Stock Titan
Weekly Recap: TMDX CFO appointment and TD Cowen $120 target - TradingView
(TMDX) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Is TransMedics Group Inc (TMDX) a Bargain After 3.4% Drop? GF Value Says Undervalued - GuruFocus
TransMedics Slides After CFO Transition News Despite Reaffirmed 2026 Outlook - quiverquant.com
TransMedics Group (NASDAQ:TMDX) Stock Price Down 4.1%What's Next? - MarketBeat
Needham reiterates Buy on TransMedics stock, names new CFO By Investing.com - Investing.com UK
TransMedics (NASDAQ: TMDX) Appoints Fernando Araujo as CFO with $590K Base Salary - Kalkine Media
TransMedics appoints Fernando Araujo as CFO to drive growth, reiterates 2026 revenue guidance of $737-$757M. - Pluang
TransMedics Appoints Fernando Araujo as CFO with Detailed Compensation and Transition Plan - Kalkine Media
TransMedics names Fernando Araujo as CFO, reaffirms 2026 outlook By Investing.com - Investing.com India
(TMDX) TransMedics Expects Full Year 2026 Revenue Range $737M$757M, vs. FactSet Est of $743.1M - marketscreener.com
TransMedics Group, Inc. Reiterates Revenue Guidance for the Full Year 2026 - marketscreener.com
TransMedics Group (NASDAQ:TMDX): Is the Market Too Cautious? - Kalkine Media
TransMedics Appoints Fernando Araujo as Chief Financial Officer and Reiterates 2026 Financial Outlook - PR Newswire
TransMedics Group, Inc. (NASDAQ:TMDX) Given Consensus Rating of "Hold" by Brokerages - MarketBeat
NFLX: Netflix Inc Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
TMDX Stock Rallies As Analyst Sees 77% Upside — Here’s Why - Stocktwits
TransMedics Group (TMDX) Institutional Ownership 2026 - MarketBeat
TMDX Reiterated by TD Cowen -- Price Target Maintained at $120 - GuruFocus
Transmedics Group Inc Azioni (TMDX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Transmedics Group Inc Azioni (TMDX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Gunderson Thomas J. | Director |
Jun 15 '26 |
Option Exercise |
2.21 |
19,285 |
42,620 |
26,266 |
| Gunderson Thomas J. | Director |
Jun 15 '26 |
Sale |
75.06 |
9,624 |
722,377 |
16,642 |
0.26%
0.38%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):